MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Pfizer

Open

SectorGezondheidszorg

25.72 -1.91

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

25.71

Max

26.47

Belangrijke statistieken

By Trading Economics

Inkomsten

-45M

2.9B

Verkoop

938M

15B

K/W

Sectorgemiddelde

13.984

37.257

EPS

0.78

Dividendrendement

6.21

Winstmarge

19.982

Werknemers

81,000

EBITDA

266M

5.3B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+8.6% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

6.21%

2.94%

Volgende Winsten

4 nov 2025

Volgende dividenddatum

1 dec 2025

Volgende Ex Dividend datum

7 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

16B

150B

Vorige openingsprijs

27.63

Vorige sluitingsprijs

25.72

Nieuwssentiment

By Acuity

36%

64%

150 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Pfizer Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 okt 2025, 08:54 UTC

Belangrijke Marktbewegers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

30 sep 2025, 15:07 UTC

Belangrijke Marktbewegers

Pfizer Shares Rise After WSJ Reports Company Will Lower Drug Costs

22 sep 2025, 14:54 UTC

Acquisities, Fusies, Overnames

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- 2nd Update

22 sep 2025, 11:51 UTC

Acquisities, Fusies, Overnames

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sep 2025, 11:09 UTC

Acquisities, Fusies, Overnames

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion

22 sep 2025, 10:13 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Metsera Shares Leap Premarket on Report of Takeover by Pfizer

22 sep 2025, 07:42 UTC

Acquisities, Fusies, Overnames

Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources

5 aug 2025, 11:34 UTC

Winsten

Pfizer Boosts 2025 Adjusted EPS Outlook Following 2Q Gains

22 sep 2025, 15:17 UTC

Acquisities, Fusies, Overnames

Pfizer Jumps Back into the Weight-Loss Race With $4.9B Acquisition -- Barrons.com

22 sep 2025, 13:43 UTC

Acquisities, Fusies, Overnames

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- Update

22 sep 2025, 11:26 UTC

Acquisities, Fusies, Overnames

These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More -- Barrons.com

22 sep 2025, 11:26 UTC

Acquisities, Fusies, Overnames

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion -- WSJ

22 sep 2025, 10:48 UTC

Acquisities, Fusies, Overnames

Pfizer: Metsera Deal Adds Four Clinical-Stage Incretin, Amylin Programs to Pipeline >PFE MTSR

22 sep 2025, 10:47 UTC

Acquisities, Fusies, Overnames

Pfizer: Metsera Deal Includes Contingent Value Rights Worth Up to Additional $22.50/Share >PFE MTSR

22 sep 2025, 10:46 UTC

Acquisities, Fusies, Overnames

Pfizer: Metsera Deal Has Initial Enterprise Value of $4.9 Billion >PFE MTSR

22 sep 2025, 10:45 UTC

Acquisities, Fusies, Overnames

Pfizer to Pay Initial $47.50/Share for Metsera >PFE MTSR

22 sep 2025, 10:45 UTC

Acquisities, Fusies, Overnames

Pfizer to Acquire Metsera and Its Next-Generation Obesity Portfolio >PFE MTSR

22 sep 2025, 09:12 UTC

Populaire aandelen

Stocks to Watch Monday: Nippon Steel, Porsche, Infosys, Metsera -- WSJ

5 aug 2025, 20:44 UTC

Winsten

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 aug 2025, 18:20 UTC

Winsten

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 aug 2025, 18:17 UTC

Winsten

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 aug 2025, 16:04 UTC

Marktinformatie

Pfizer's New Tax Rate Helps Boost Adj EPS Outlook -- Market Talk

5 aug 2025, 15:25 UTC

Winsten

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 aug 2025, 13:56 UTC

Winsten

Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain. -- Barrons.com

5 aug 2025, 11:43 UTC

Winsten

Pfizer Stock Pops as Earnings Smash Expectations. Guidance Hiked in Face of Tariffs. -- Barrons.com

5 aug 2025, 11:27 UTC

Winsten

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 aug 2025, 10:57 UTC

Winsten

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked. -- Barrons.com

5 aug 2025, 10:55 UTC

Winsten

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 aug 2025, 10:53 UTC

Winsten

Pfizer Boosts 2025 Profit Estimate In A Sign Of 'Confidence' -- MarketWatch

5 aug 2025, 10:51 UTC

Winsten

Pfizer: On Track to Deliver About $7.2B Overall Cost Savings From Cost-Improvement Initiatives b/ End of 2027 >PFE

Peer Vergelijking

Prijswijziging

Pfizer Prognose

Koersdoel

By TipRanks

8.6% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 28.53 USD  8.6%

Hoogste 34 USD

Laagste 24 USD

Gebaseerd op 17 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pfizer - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

17 ratings

4

Buy

12

Hold

1

Sell

Technische score

By Trading Central

22.855 / 23.85Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

150 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat